Ingmar Jungner
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study.
Journal: Frontiers in oncology
Published: November 01, 2019
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis.
Journal: BMC molecular and cell biology
Published: March 12, 2019
Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort.
Journal: Cancer causes & control : CCC
Published: July 09, 2018
Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
Journal: BMC cancer
Published: February 13, 2018
Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS study.
Journal: Diabetes, obesity & metabolism
Published: November 24, 2017
Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort.
Journal: BMC cancer
Published: August 10, 2017
Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum.
Journal: Oncotarget
Published: July 25, 2017
Gunnar Jungner and the Principles and Practice of Screening for Disease.
Journal: International journal of neonatal screening
Published: June 27, 2017
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study.
Journal: International journal of cancer
Published: June 09, 2017
Serum biomarkers to predict risk of testicular and penile cancer in AMORIS.
Journal: Ecancermedicalscience
Published: March 27, 2017
Last Updated: 09/26/2026